Psychopathology of schizophrenia and schizoaffective disorder in comparison with the indices of cell-mediated immunity in HIV-infected patients
Suggested citation:
Polyanskiy DA, Kalinin VV. [Psychopathology of schizophrenia and schizoaffective disorder in comparison with the indices of cell-mediated immunity in HIV-infected patients]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2019;(3):46-51. Russian
In observational study researched the interrelation of psychopathological syndromes and the state of cellular immunity in HIV-infected patients with schizophrenia and schizoaffective disorder. We have used comparison of means and regression analysis. HIV infection affects individual indicators of the effector level of cellular immunity in patients with paranoid schizophrenia and schizoaffective disorder, while it differs in schizophrenia and schizoaffective disorder and in various forms of schizophrenia. The structure of psychopathological disorders in HIV-infected patients with schizophrenia and schizoaffective disorder correlates with the immunoregulatory index CD4+/CD8+, which reflects the involvement of the effector cell-mediated immunity in the formation of a clinic of endogenous disorders.
Keywords schizophrenia; schizoaffective disorder; psychopathology; HIV; infection; immunoregulatory index
1. Müller N, Ackenheil M, Hofschuster E, et al. Cellular immunity in schizophrenic patients before and during neuroleptic treatment. Psychiatry Research. 1991;37(2):147–60. DOI: 10.1016/0165-1781(91)90072-w 2. Klushnik TP, Brusov OS, Burbaeva GSh, Kolyaskina GI. Modern view on the basic pathogenetic hypotheses of schizophrenia. Psychiatry. 2010;1(43):7–13. Russian. 3. SHCHerbakova IV. Osobennosti vrozhdennogo i priobretennogo immuniteta pri vysokom riske vozniknoveniya shizofrenii i v processe ee razvitiya [PhD thesis]. [Moscow (Russia)]: Nauchnyj centr psihicheskogo zdorov'ya [Mental Health Center, Moscow]; 2006. 245 p. Russian. 4. Kostyukova AB, Mosolov SN. Sovremennaya terapiya psihicheskih rasstrojstv. Nejrovospalitel'naya gipoteza shizofrenii i nekotorye novye terapevticheskie podhody. Psihofarmakoterapiya. 2013;4:8–17. Russian. www.psypharma.ru 5. Watanabe Y, Someya T, Nawa H. Cytokine hypothesis of schizophrenia pathogenesis: Evidence from human studies and animal models. Psych and Clinical Neurosciences. 2010;64(3):217–30. DOI: 10.1111/j.1440-1819.2010.02094.x 6. Polyanskiy DA, Kalinin VV, Olshanskiy AYa. [The clinical and biological relationships in HIV-infected patients with schizophrenia and schizoaffective disorder]. Psychiatry. 2018;(02):73–8. DOI: 10.30629/2618-6667-2018-78-73-78 7. Hennederg A, Riedl H, Dumke H-O, Kornhuber HH. T-lymphocyte subpopulations in schizophrenia patients. European Archives of Psychiatry and Neurological. 1990;239(5):283–4. DOI: 10.1007/bf01735051 8. Ganguli R, Rabin BS, Brar JS. Antinuclear and gastric parietal cell autoantibodies in schizophrenic patients. Biological Psychiatry. 1992;32(8):735–8. DOI: 10.1016/0006-3223(92)90306-k 9. Adler MW. ABC of AIDS. Development of the epidemic. British Medical Journal. 1987;294(6579):1083–5. DOI: 10.1136/bmj.294.6579.1083 10. Pokrovskij VV, Ermak TN, Belyaeva VV, YUrin OG. VICH-infekciya: klinika, diagnostika. Pod obshchej red. VV Pokrovskogo. Moscow: GEHOTAR-Media, 2000. 496 p. Russian. 11. Daruna JH. Introduction to Psychoneuroimmunology. Academic Press. Elsevier. Amsterdam. 2004. 280 р. 12. Yeung H, Krentz HB, Gill MJ, Power С. Neuropsychiatric disorders in HIV infection: impact of diagnosis on economic costs of care. AIDS. 2006;20(16):2005–9. DOI: 10.1097/01.aids.0000247565.80633.d2 13. Neznanov NG, Halezova NB. Rasprostranyonnost' i harakter psihicheskih rasstrojstv u VICH-inficirovannyh bol'nyh S.-Peterburga. Psihicheskie rasstrojstva v obshchej medicine. 2007;2:14–7. Russian. 14. Querques J, Freudenreich O. Psychiatric aspects of HIV infection and AIDS. In Massachusetts General Hospital. Comprehensive Clinical Psychiatry. TA Stern, M Fava, TE Wilens, JF Rosenbaum Rosenbaum (Eds). 2nd Ed. Elsevier. 2016. Ch. 57. P. 627–37. 15. Hritinin DF, Novikov VV. Psihicheskie rasstrojstva pri VICH-infekcii v XXI veke. Moscow: BINOM, 2016. 224 p. Rusian. 16. David AS, Fleminger S, Kopelman MD, et al. Lishman’s organic psychiatry: a textbook of neuropsychiatry. 4th Ed. Willey-Blackwell. AJ Chichester, W Sussex, UK. 2009. Part 2. Ch. 7. P. 397–472. DOI: 10.1002/9781444316803 17. Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale – SCI-PANSS. Multi-Health System Inc. 1986, 1992, 1999. 11 p. 18. Mosolov SN. SHkaly psihometricheskoj ocenki simptomatiki shizofrenii i koncepciya pozitivnyh i negativnyh rasstrojstv. Moscow; 2001. 238 p. 19. Petrilowitsch N. Typology and therapy of schizophrenias. Int. Pharmacopsychiatry. 1969;3(3–4):175–85. 20. Polyansky DA, Kalinin VV, Mazus AI, Olshansky AYA. [Immunological and psychopathological characteristics of HIV-infected schizophrenic patients]. Zh Nevrol Psikhiatr Im SS Korsakova. 2013;113(11):74–7. Russian.
DOI: http://dx.doi.org/10.24411/1560-957X-2019-11928
Article Metrics
Metrics powered by PLOS ALM